Rossmore Private Capital’s Thermo Fisher Scientific TMO Stock Holding History

Rossmore Private Capital’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.44M	Sell	4,857 -8	-0.2%	-$3.84K	0.2%	88
2026 Q1	$2.39M	Buy	4,865 +152	+3%	+$82.5K	0.21%	84
2025 Q4	$2.73M	Buy	4,713 +340	+8%	+$192K	0.24%	77
2025 Q3	$2.12M	Sell	4,373 -73	-2%	-$34K	0.23%	82
2025 Q2	$1.8M	Sell	4,446 -206	-4%	-$86.1K	0.21%	86
2025 Q1	$2.31M	Buy	4,652 +24	+0.5%	+$13K	0.29%	69
2024 Q4	$2.39M	Sell	4,628 -20	-0.4%	-$11K	0.3%	70
2024 Q3	$2.88M	Sell	4,648 -6	-0.1%	-$3.55K	0.36%	59
2024 Q2	$2.57M	Sell	4,654 -12	-0.3%	-$6.88K	0.34%	62
2024 Q1	$2.71M	Sell	4,666 -28	-0.6%	-$15.7K	0.35%	63
2023 Q4	$2.49M	Sell	4,694 -1	-0%	-$484	0.35%	64
2023 Q3	$2.38M	Sell	4,695 -21	-0.4%	-$11.2K	0.36%	59
2023 Q2	$2.46M	Sell	4,716 -63	-1%	-$34K	0.37%	59
2023 Q1	$2.75M	Sell	4,779 -240	-5%	-$135K	0.43%	56
2022 Q4	$2.76M	Sell	5,019 -222	-4%	-$118K	0.44%	57
2022 Q3	$2.66M	Buy	5,241 +22	+0.4%	+$12.3K	0.48%	51
2022 Q2	$2.83M	Buy	5,219 +6	+0.1%	+$3.3K	0.49%	51
2022 Q1	$3.08M	Hold	5,213	–	–	0.48%	56
2021 Q4	$3.48M	Buy	5,213 +144	+3%	+$89.9K	0.54%	51
2021 Q3	$2.9M	Sell	5,069 -1	-0%	-$549	0.5%	53
2021 Q2	$2.56M	Sell	5,070 -52	-1%	-$24.5K	0.44%	57
2021 Q1	$2.34M	Buy	5,122 +284	+6%	+$136K	0.44%	59
2020 Q4	$2.25M	Sell	4,838 -112	-2%	-$52.5K	0.46%	58
2020 Q3	$2.19M	Buy	4,950 +355	+8%	+$147K	0.51%	52
2020 Q2	$1.67M	Buy	4,595 +2,129	+86%	+$714K	0.46%	57
2020 Q1	$699K	Buy	+2,466	New	+$778K	0.24%	89
2018 Q1	–	Sell	-173	Closed	-$32.8K	–	375
2017 Q4	$32.8K	Buy	+173	New	+$33.1K	0.03%	201

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Rossmore Private Capital's TMO Position: Q2 2026 in Review

Rossmore Private Capital reduced its Thermo Fisher Scientific (TMO) stake by 0.16% in Q2 2026, selling an estimated $3.84K and leaving 4,857 shares worth $2.44M. The position accounts for 0.2% of the portfolio, ranked #88.

Rossmore Private Capital first reported a position in TMO in Q4 2017 and has held it in 27 quarters since. The position peaked at $3.48M in Q4 2021. 2,623 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Rossmore Private Capital held 4,857 shares of Thermo Fisher Scientific worth $2.44M as of Q2 2026.
Rossmore Private Capital sold 8 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.84K.
Thermo Fisher Scientific made up 0.2% of Rossmore Private Capital's portfolio in Q2 2026, its #88 holding.
Rossmore Private Capital first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 27 quarters since.
Rossmore Private Capital's Thermo Fisher Scientific position peaked at $3.48M in Q4 2021.
2,623 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.